<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31719006</article-id><article-id pub-id-type="pmc">6852447</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2019-0064</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The Factors Affecting Rhythm Control for Cryoablation of Atrial
Fibrillation in Mitral Valve Surgery</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5360-4671</contrib-id><name><surname>T&#x000fc;rker</surname><given-names>Fevzi Sarper</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Erdogan</surname><given-names>Mustafa Bilge</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Dogan</surname><given-names>Ay&#x0015f;e</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>Department of Cardiovascular Surgery, University of Health Sciences,
Elaz&#x00131;&#x0011f; Training and Research Hospital, Elaz&#x00131;&#x0011f;,
Turkey.</aff><aff id="aff2">
<label>2</label>Department of Cardiovascular Surgery, Bah&#x000e7;e&#x0015f;ehir
University Medical School, Istanbul, Turkey.</aff><aff id="aff3">
<label>3</label>Department of Physiotherapy and Rehabilitation, Bitlis Eren
University Health High School, Bitlis, Turkey.</aff><author-notes><corresp id="c1">Correspondence Address: <bold>Fevzi Sarper T&#x000fc;rker</bold>,
<ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-5360-4671">https://orcid.org/0000-0002-5360-4671</ext-link>, University of Health
Sciences, Elaz&#x00131;&#x0011f; Training and Research Hospital, Cardiovascular
Surgery Clinic, R&#x00131;zaiye Mah. Elaz&#x00131;&#x0011f;, Turkey - Zip Code:
23000. E-mail: <email>sarperturker@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Sep-Oct</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2019</year></pub-date><volume>34</volume><issue>5</issue><fpage>525</fpage><lpage>534</lpage><history><date date-type="received"><day>15</day><month>2</month><year>2019</year></date><date date-type="accepted"><day>29</day><month>5</month><year>2019</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>To evaluate the factors impacting on the conversion to sinus rhythm and on
the postoperative rhythm findings in the six-month follow-up period of a
mitral valve surgery combined with cryoablation Cox-Maze III procedure, in
patients with atrial fibrillation.</p></sec><sec><title>Methods</title><p>In this study, we evaluated 80 patients who underwent structural valve
disease surgery in combination with cryoablation. Indications for the
surgical procedures were determined in the patients according to the
presence of rheumatic or non-rheumatic structural disorders in the mitral
valve as evaluated by echocardiography. Cox-Maze III procedure and left
atrial appendix closure were applied.</p></sec><sec><title>Results</title><p>The results of receiver operating characteristics analysis indicated that the
rate of conversion to the sinus rhythm was significantly higher in patients
with left atrial diameters &#x02265; 45.5 mm and with ejection fraction (EF)
&#x02265; 48.5%. However, the statistical differences disappeared in the
sixth month. Thromboembolic (TE) events were seen only in three patients in
the early period and no more TE events occurred in the six-month follow-up
period.</p></sec><sec><title>Conclusion</title><p>The EF and the preoperative left atrial diameter were determined to be the
factors impacting on the conversion to sinus rhythm in patients who
underwent mitral valve surgery in combination with cryoablation. Mitral
valve surgery in combination with ablation for atrial fibrillation does not
affect mortality and morbidity in the experienced health centers; however,
it remains controversial whether it will provide additional health benefits
to the patients compared to those who underwent only mitral valve
surgery.</p></sec></abstract><kwd-group><kwd>Mitral Valve</kwd><kwd>Cryosurgery</kwd><kwd>Atrial Fibrillation</kwd><kwd>Cox-Maze III</kwd><kwd>Heart Atria</kwd><kwd>Thromboembolism</kwd><kwd>Echocardiography</kwd></kwd-group></article-meta></front><body><table-wrap id="t7" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="4%" span="1"/><col width="44%" span="1"/><col width="4%" span="1"/><col width="4%" span="1"/><col width="44%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</th><th align="center" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Atrial fibrillation</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">MVS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Mitral valve
surgery</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AUC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Area under the
curve</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PV</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Pulmonary veins</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AVR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Aortic valve
replacement</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ROC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Receiver operating
characteristics</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery bypass
grafting</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Standard deviation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CPB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiopulmonary
bypass</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SE</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Standard error</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ECG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Electrocardiogram</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SPSS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Statistical Package for
the Social Sciences</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">EF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Ejection fraction</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Sinus rhythm</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LAD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left atrial
diameter</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">TE</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Thromboembolic</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">MVR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Mitral valve
replacement</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Atrial fibrillation (AF) is the most common cardiac arrhythmia in the daily clinical
practice, leading to increased incidences of thromboembolic (TE) events and
mortality<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. The rates of
AF in adults were estimated to increase by two folds at each consecutive decade and
it has been shown that 70% of the individuals with AF are between the ages of 65 and
80 years<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>.</p><p>The AF incidence is high in patients in whom mitral valve surgery (MVS) is
indicated<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. At the same
time, this condition is a factor increasing mortality<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. The cardiology and cardiac surgery societies
frequently update the AF treatment guidelines with the results of many clinical and
physiological studies<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>.</p><p>The Cox-Maze III procedure is currently the golden standard in the surgical treatment
of AF, achieving success rates &#x0003e; 90%<sup>[<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref>]</sup>. Consequently,
after the achievement of these success rates, the surgical treatment of AF has been
standardized by the evolving modified versions of the maze procedure<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>. However, the procedure's way of
preventing the mechanism causing AF recurrences has not been clarified yet. The
paramount theory to explain the procedure's protective effect against the
development of AF proposes that the right and the left atrial conduction blocks are
created and macro reentry circuits are prevented<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p><p>MVS in combination with surgical AF ablation allows patients to remain in the sinus
rhythm (SR) in the short and middle-term periods compared to the MVS performed
alone; however, no differences were observed when these two groups were compared in
terms of the following measures and events including the 30-day mortality, all-cause
mortality, pacemaker implantation, stroke, and TE events<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. According to the patients&#x02019; records and
retrospective analyses, the application of the maze procedure in combination with
the MVS does not lead to increased rates of mortality<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>.</p><p>We evaluated some factors impacting on the conversion to SR in patients with AF who
underwent MVS combined with cryoablation.</p></sec><sec sec-type="methods"><title>METHODS</title><sec><title>Patients</title><p>Eighty patients with left-sided valvular heart disease, suffering from medical
treatment-resistant AF (6.25% paroxysmal and 93.75% persistent AF), who were
treated in the period between January 2013 and November 2016 were included in
the study. The patients were retrospectively evaluated using the information in
the digital records of the hospital and in the patients&#x02019; files. The indications
of MVS were determined by means of transthoracic or transesophageal
echocardiography in all patients. Coronary angiography was performed
preoperatively in all patients over 45 years old. It was determined whether the
patients, who were followed up by the cardiologists, had paroxysmal or
persistent AF. The patients with comorbid aortic and/or tricuspid valve
diseases, as well as those requiring coronary revascularization, were included
in the study too. Patients with infective endocarditis or adult congenital heart
disease and those with a history of open-heart surgery or invasive procedures
for the treatment of AF were excluded. Routine hematological tests and
urinalysis, as well as radiological diagnostics, were performed preoperatively
in all patients in order to ensure that no contraindications existed to perform
the surgical procedures (<xref rid="t1" ref-type="table">Table 1</xref>).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Descriptive statistics for the patients' characteristics.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="33%" span="1"/><col width="33%" span="1"/><col width="33%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Characteristic</th><th align="center" rowspan="1" colspan="1">Male</th><th align="center" rowspan="1" colspan="1">Female</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1"><bold>Count (percent)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Count (percent)</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Number of patients</td><td align="center" rowspan="1" colspan="1">31 (38.75)</td><td align="center" rowspan="1" colspan="1">49 (61.25)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1"><bold>Mean&#x000b1;SE mean</bold></td><td align="center" rowspan="1" colspan="1"><bold>Mean&#x000b1;SE mean</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">48&#x000b1;11.13</td><td align="center" rowspan="1" colspan="1">46&#x000b1;13.31</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative left atrial diameter</td><td align="center" rowspan="1" colspan="1">48&#x000b1;4.71</td><td align="center" rowspan="1" colspan="1">47&#x000b1;4.61</td></tr><tr><td align="left" rowspan="1" colspan="1">Left ventricular ejection fraction (%)</td><td align="center" rowspan="1" colspan="1">53&#x000b1;6.86</td><td align="center" rowspan="1" colspan="1">52&#x000b1;6.94</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1"><bold>Count (percent)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Count (percent)</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Paroxysmal AF</td><td align="center" rowspan="1" colspan="1">2 (2.50)</td><td align="center" rowspan="1" colspan="1">3(3.75)</td></tr><tr><td align="left" rowspan="1" colspan="1">History of embolic stroke</td><td align="center" rowspan="1" colspan="1">1 (1.25)</td><td align="center" rowspan="1" colspan="1">1(1.25)</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative heart failure</td><td align="center" rowspan="1" colspan="1">4 (5.00)</td><td align="center" rowspan="1" colspan="1">7 (8.75)</td></tr><tr><td align="left" rowspan="1" colspan="1">Coronary artery disease</td><td align="center" rowspan="1" colspan="1">9 (11.25)</td><td align="center" rowspan="1" colspan="1">6 (7.50)</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1">14 (17.50)</td><td align="center" rowspan="1" colspan="1">22 (27.50)</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes mellitus</td><td align="center" rowspan="1" colspan="1">4 (5.00)</td><td align="center" rowspan="1" colspan="1">14 (17.50)</td></tr><tr><td align="left" rowspan="1" colspan="1">Lung disease</td><td align="center" rowspan="1" colspan="1">8 (10.00)</td><td align="center" rowspan="1" colspan="1">7 (8.75)</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>AF=atrial fibrillation; SE=standard error</p></fn></table-wrap-foot></table-wrap><p>This study was approved by our hospital's institutional Ethics Committee, which
waived the requirement for patient informed consent because of the retrospective
nature of the study.</p></sec><sec><title>Surgical Procedures</title><p>All patients and their relatives had been informed clearly about the procedure
before surgery and written consent forms had been obtained previously. All
patients were operated by cardiopulmonary bypass procedure, undergoing standard
sternotomy under general anesthesia. MVS and cryoablation with Cox-Maze III
procedure were performed in the flaccid heart with cross-clamping.</p><p>Induction of general anesthesia was performed in all patients undergoing surgery.
A median sternotomy was also performed in all patients. Heparin (350-400
unit/kg) was administered to the patients followed by routine aortic and bicaval
cannulation. Membrane oxygenators were used, and moderate systemic hypothermia
was applied to perform the cardiopulmonary bypass (CPB) procedure. Myocardial
protection was achieved by using antegrade and retrograde mild hypothermic blood
cardioplegia (at 32&#x000b0;C), repeated every 20 minutes. The mitral valve procedure
was carried out by entering through the Waterstons&#x02019; groove or by entering the
left atrium from the right atrium via the transseptal way. The transseptal
approach was preferred in 25 patients with small left atria or with enlarged
left atria extending posteriorly as detected by echocardiography. Primarily, the
mitral valve, the orifices of the left atrial auriculae, and the orifices of the
pulmonary veins (PV) were examined. Before the mitral valve procedure, the left
atrial auriculae were amputated externally and the resulting defect was closed
by continuous suturing. Following this procedure, the cryoablation technique was
applied to the left atrium; complying with the standard schema (argon-based
CryoMaze, CryoFlex Medtronic, Minneapolis, Minnesota, United States of America).
After the orifices of the PV were ablated in the posterior walls of the atria,
the lines were extended to the mitral valve annulus and left atrial auriculae
(<xref ref-type="fig" rid="f1">Figure 1</xref>). Following the ablation, MVS
was performed.</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Schematic view of cryoablation of Cox-Maze III procedure.</p></caption><graphic xlink:href="rbccv-34-05-0525-g01"/></fig>
</p><p>Three patients underwent flexible mitral annuloplasty (mitral annuloplasty ring
SJM Tailor<sup>TM</sup>) and artificial heart valve replacements were performed
in 77 patients (71 mechanical and six biological valvular prostheses from St
Jude Medical were used). Left atrial thrombectomy was performed in 19 (23.75%)
patients. Aortic valve replacements were performed in eight patients and
coronary revascularizations were performed in three patients in combination with
mitral valve replacement. Tricuspid valve repairs were performed in 17 patients.
Coronary revascularizations were performed in 15 of 80 patients and the mean
number of the grafting was 1.4 (<xref rid="t2" ref-type="table">Table
2</xref>).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Descriptive statistics for surgical procedures and postoperative
results.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="30%" span="1"/><col width="30%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Male</th><th align="center" rowspan="1" colspan="1">Female</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1"><bold>Count (percent)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Count (percent)</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Number of patients, n</td><td align="center" rowspan="1" colspan="1">31 (38.75)</td><td align="center" rowspan="1" colspan="1">49 (61.25)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mitral ring annuloplasty, n</td><td align="center" rowspan="1" colspan="1">1 (1.25)</td><td align="center" rowspan="1" colspan="1">2 (2.50)</td></tr><tr><td align="left" rowspan="1" colspan="1">MVR + AVR, n</td><td align="center" rowspan="1" colspan="1">2 (2.50)</td><td align="center" rowspan="1" colspan="1">6 (7.50)</td></tr><tr><td align="left" rowspan="1" colspan="1">MVR + AVR + CABG, n</td><td align="center" rowspan="1" colspan="1">2 (2.50)</td><td align="center" rowspan="1" colspan="1">1(1.25)</td></tr><tr><td align="left" rowspan="1" colspan="1">MVR+ CABG, n</td><td align="center" rowspan="1" colspan="1">8 (10)</td><td align="center" rowspan="1" colspan="1">4 (5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Tricuspid valve annuloplasty, n</td><td align="center" rowspan="1" colspan="1">6 (7.50)</td><td align="center" rowspan="1" colspan="1">11 (13.75)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1"><bold>Mean&#x000b1;SE mean</bold></td><td align="center" rowspan="1" colspan="1"><bold>Mean&#x000b1;SE mean</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Cross-clamp time, min</td><td align="center" rowspan="1" colspan="1">71&#x000b1;5.15</td><td align="center" rowspan="1" colspan="1">71&#x000b1;6.19</td></tr><tr><td align="left" rowspan="1" colspan="1">Total CPB time, min</td><td align="center" rowspan="1" colspan="1">103&#x000b1;11.26</td><td align="center" rowspan="1" colspan="1">106&#x000b1;11.64</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1"><bold>Count (percent)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Count (percent)</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Left atrial thrombus, n</td><td align="center" rowspan="1" colspan="1">6 (7.50)</td><td align="center" rowspan="1" colspan="1">13 (16.25)</td></tr><tr><td align="left" rowspan="1" colspan="1">Temporary pacemaker, n</td><td align="center" rowspan="1" colspan="1">4 (5)</td><td align="center" rowspan="1" colspan="1">10 (12.50)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mechanical artificial heart valve, n</td><td align="center" rowspan="1" colspan="1">28 (35)</td><td align="center" rowspan="1" colspan="1">43 (53.75)</td></tr><tr><td align="left" rowspan="1" colspan="1">Biological artificial heart valve, n</td><td align="center" rowspan="1" colspan="1">2 (2.50)</td><td align="center" rowspan="1" colspan="1">4 (5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Permanent pacemaker, n</td><td align="center" rowspan="1" colspan="1">2 (2.50)</td><td align="center" rowspan="1" colspan="1">4 (5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative sinus, n</td><td align="center" rowspan="1" colspan="1">23 (28.75)</td><td align="center" rowspan="1" colspan="1">38 (47.50)</td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative thromboembolic event, n</td><td align="center" rowspan="1" colspan="1">1 (1.25)</td><td align="center" rowspan="1" colspan="1">2 (2.50)</td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative permanent thromboembolic event,
n</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">1 (1.25)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1"><bold>Mean&#x000b1;SE mean</bold></td><td align="center" rowspan="1" colspan="1"><bold>Mean&#x000b1;SE mean</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Duration of hospitalization (days), n</td><td align="center" rowspan="1" colspan="1">8&#x000b1;3.12</td><td align="center" rowspan="1" colspan="1">10&#x000b1;5.01</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>AVR=aortic valve replacement; CABG=coronary artery bypass grafting;
CPB=cardiopulmonary bypass; MVR=mitral valve replacement;
SE=standard error</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Postoperative Management and Rhythm Assessments</title><p>All patients were transferred to the intensive care unit under mechanical
ventilation support. Invasive arterial pressure and electrocardiogram (ECG)
monitorization were performed in all patients at the intensive care unit and the
patients' daily ECGs were recorded. All patients with acceptable levels of
bleeding started anticoagulation treatment with enoxaparin and adjunctive
warfarin. Enoxaparin treatment stopped when the international normalized ratios
were &#x0003e; 2. Some of the patients received an oral beta-blocker (metoprolol)
administered in individually adjusted doses for rhythm control. Central TE
events occurred in three patients postoperatively. Of these three patients, two
were the patients who underwent left atrial thrombectomy. One of these three
patients had hemiparesis at the time of discharge; however, two of them were
discharged without any neurological sequela.</p><p>ECG recordings were made every six hours in the early postoperative period. In
order to evaluate the cardiac rhythm, daily recordings of the ECGs were kept in
the inpatient service too. Patients started amiodarone infusion if AF occurred
early postoperatively. Conversion to SR did not occur in three patients;
therefore, cardioversion was applied to them in the intensive care unit under
sedation by midazolam. Eventually, conversion to SR developed in both of these
patients (<xref ref-type="fig" rid="f2">Figure 2</xref>).</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Summary of patients.</p></caption><graphic xlink:href="rbccv-34-05-0525-g02"/></fig>
</p></sec><sec><title>Statistical Analysis</title><p>As the data determined by the measurements were characterized as more or less
with a certain rating, they were subjected to receiver operating characteristics
(ROC) analysis and Chi-square independent samples test. The Statistical Package
for the Social Sciences (SPSS) software, version 20.0, was used. The results
were interpreted according to a <italic>P</italic>-value of &#x0003c; 0.05.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>ROC analysis conducted to determine the cutoff values for the measured values of the
preoperative left atrial diameter (LAD) and the ejection fraction (EF) revealed that
the area under the curve (AUC) value reached a level over 0.60 (0.633 and 0.613) for
the preoperative LAD when the &#x0201c;sinus rhythm on the day of discharge&#x0201d; and the &#x0201c;sinus
rhythm in the first month&#x0201d; were used as variables. The point where the sensitivity
and specificity values were the highest was accepted as the cutoff value (<xref ref-type="fig" rid="f3">Figures 3</xref> and <xref ref-type="fig" rid="f4">4</xref>; <xref rid="t3" ref-type="table">Tables 3</xref> and <xref rid="t4" ref-type="table">4</xref>). <xref ref-type="fig" rid="f3">Figure
3</xref> and <xref rid="t3" ref-type="table">Table 3</xref> show that a cutoff
value of 44.5 mm with a sensitivity of 0.797 and a specificity of 0.562
(1-specificity = 0.438) may be accepted for the preoperative LAD variable when the
rhythm on the day of discharge was used. When the &#x0201c;sinus rhythm at the first month&#x0201d;
was used as a variable (<xref ref-type="fig" rid="f4">Figure 4</xref> and <xref rid="t4" ref-type="table">Table 4</xref>), a cutoff value of 45.5 mm could be
accepted (sensitivity = 0.721 and specificity = 0.579) for the preoperative LAD
variable.</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>ROC curve for the preoperative LAD value - sinus rhythm on the day of
discharge. LAD=left atrial diameter; ROC=receiver operating
characteristics.</p></caption><graphic xlink:href="rbccv-34-05-0525-g03"/></fig>
</p><p>
<fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>ROC curve for the preoperative LAD values - sinus rhythm in the first
month. LAD=left atrial diameter; ROC=receiver operating
characteristics.</p></caption><graphic xlink:href="rbccv-34-05-0525-g04"/></fig>
</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Coordinates of the curve for preoperative LAD values - sinus rhythm on the
day of discharge.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="33%" span="1"/><col width="33%" span="1"/><col width="33%" span="1"/></colgroup><thead><tr><th align="left" colspan="3" rowspan="1">Coordinates of the curve:</th></tr><tr><th align="center" rowspan="1" colspan="1">Positive if greater than or equal to<sup><xref ref-type="table-fn" rid="TFN4">a</xref></sup></th><th align="center" rowspan="1" colspan="1">Sensitivity</th><th align="center" rowspan="1" colspan="1">1 - Specificity</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">44.5000 (cutoff value)</td><td align="center" rowspan="1" colspan="1">0.797</td><td align="center" rowspan="1" colspan="1">0.438</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p>Test results: Preoperative LAD had at least one tie between the positive
actual state group and the negative actual state group.</p></fn><fn id="TFN4"><label>a</label><p>The smallest cutoff value is the minimum observed test value minus 1, and
the largest cutoff value is the maximum observed test value plus 1. All
the other cutoff values are the averages of two consecutively ordered
observed test values.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Coordinates of the curve for preoperative LAD values - sinus rhythm in the
first month.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="33%" span="1"/><col width="33%" span="1"/><col width="33%" span="1"/></colgroup><thead><tr><th align="left" colspan="3" rowspan="1">Coordinates of the curve:</th></tr><tr><th align="center" rowspan="1" colspan="1">Positive if greater than or equal to<sup><xref ref-type="table-fn" rid="TFN6">a</xref></sup></th><th align="center" rowspan="1" colspan="1">Sensitivity</th><th align="center" rowspan="1" colspan="1">1 - Specificity</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">45.5000 (cutoff value)</td><td align="center" rowspan="1" colspan="1">0.721</td><td align="center" rowspan="1" colspan="1">0.421</td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><p>Test results: Preoperative LAD had at least one tie between the positive
actual state group and the negative actual state group.</p></fn><fn id="TFN6"><label>a</label><p>The smallest cutoff value is the minimum observed test value minus 1, and
the largest cutoff value is the maximum observed test value plus 1. All
the other cutoff values are the averages of two consecutively ordered
observed test values.</p></fn></table-wrap-foot></table-wrap><p>Based on the ROC analysis&#x02019; results defining the cutoff value for the preoperative
LAD, the Chi-square test revealed that the rate of conversion to SR was
statistically significantly higher in the group with preoperative LAD values
&#x02265; 46 mm compared to the group with preoperative LAD &#x02264; 45 mm (<xref rid="t5" ref-type="table">Table 5</xref>).</p><table-wrap id="t5" orientation="portrait" position="float"><label>Table 5</label><caption><p>Comparison between two groups of patients (preoperative LAD &#x02264; 45 mm in
one group and &#x02265; 46 mm in another group).</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Preoperative LAD</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">&#x02264; 45 mm</th><th align="center" rowspan="1" colspan="1">&#x02265; 46 mm</th><th align="center" rowspan="1" colspan="1">X<sup>2</sup></th><th align="center" rowspan="1" colspan="1">SD</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Postoperative SR</td><td align="center" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">0.520</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.471</td></tr><tr><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">58</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Temporary pacemaker Total</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">0.010</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.921</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">58</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">SR on the day of discharge</td><td align="center" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">8.292</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">51</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">58</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">SR in the first month</td><td align="center" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4.934</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.026</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">58</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">SR in the sixth month</td><td align="center" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">2.737</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.098</td></tr><tr><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">58</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="TFN7"><p>LAD=left atrial diameter; SD=standard deviation; SR=sinus rhythm</p></fn></table-wrap-foot></table-wrap><p>The AUC for the EF variable achieved a value of 0.601 when the &#x0201c;postoperative sinus
rhythm&#x0201d; variable was used alone (<xref ref-type="fig" rid="f5">Figure 5</xref> and
<xref rid="t6" ref-type="table">Table 6</xref>). When <xref ref-type="fig" rid="f5">Figure 5</xref> and <xref rid="t6" ref-type="table">Table 6</xref> were
evaluated in combination, a cutoff value of 48.5% could be accepted for EF, using
the &#x0201c;postoperative sinus rhythm&#x0201d; variable with a sensitivity of 0.787 and
specificity of 0.494 (1-specificity = 0.506).</p><p>
<fig id="f5" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>ROC curves for ejection fraction value - postoperative sinus rhythm.
ROC=receiver operating characteristics.</p></caption><graphic xlink:href="rbccv-34-05-0525-g05"/></fig>
</p><table-wrap id="t6" orientation="portrait" position="float"><label>Table 6</label><caption><p>Coordinates of the curve for ejection fraction (EF) values - postoperative
sinus rhythm.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="33%" span="1"/><col width="33%" span="1"/><col width="33%" span="1"/></colgroup><thead><tr><th align="left" colspan="3" rowspan="1">Coordinates of the curve:</th></tr><tr><th colspan="3" align="left" rowspan="1">Test result variable(s): %EF</th></tr><tr><th align="center" rowspan="1" colspan="1">Positive if greater than or equal to<sup><xref ref-type="table-fn" rid="TFN9">a</xref></sup></th><th align="center" rowspan="1" colspan="1">Sensitivity</th><th align="center" rowspan="1" colspan="1">1 - Specificity</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">48.5000 (cutoff value)</td><td align="center" rowspan="1" colspan="1">0.787</td><td align="center" rowspan="1" colspan="1">0.506</td></tr></tbody></table><table-wrap-foot><fn id="TFN8"><p>The test result variable(s)=EF has at least one tie between the positive
actual state group and the negative actual state group.</p></fn><fn id="TFN9"><label>a</label><p>The smallest cutoff value is the minimum observed test value minus 1, and
the largest cutoff value is the maximum observed test value plus 1. All
the other cutoff values are the averages of two consecutively ordered
observed test values.</p></fn></table-wrap-foot></table-wrap><p>The ECGs of 61 (76.25%) out of 80 patients displayed SR during their course in the
early postoperative period; whereas five (6.25%) of the patients remained in AF.
Fourteen (17.5%) out of 80 patients required temporary pacemakers and permanent
pacemakers were implanted in six (7.5%) of them (the implantations were performed in
the early period in four patients and in the late period in two patients).</p><p>The ECGs of 61 (76.25%) out of 80 patients displayed SR in the first month of the
postoperative period. Conversion to AF occurred in three more (72.5%) patients in
the 6<sup>th</sup> month of the postoperative period. The factors impacting on the
conversion to SR in the early postoperative period and on its maintenance were
assessed in patients with AF who underwent MVS and with adjunctive Cox-Maze III
procedure by cryoablation. On the other hand, when patients were grouped as the ones
with LAD &#x02264; 45 mm and patients with LAD &#x02265; 46 mm, the rates of remaining
in SR were in favor of the latter group on the day of discharge and in the first
postoperative month (<italic>P</italic>&#x0003c;0.004, <italic>P</italic>&#x0003c;0.026).</p><p>No statistically significant results were detected with ROC analysis when patients
were classified in terms of the duration of CPB and cross-clamp period. There were
no differences between the groups when the patients were classified according to
gender.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Isolation of PV from the atrial tissue treats AF in 65-80% of AF patients as current
studies have shown that the largest ectopic foci initiating AF are the PV. In
addition to the PV, other cardiac structures may be the ectopic foci at a rate of
20%, including the superior vena cava, free wall of the left atrium, terminal crest,
coronary sinus ostium, Marshall ligament, and interatrial septum. In chronic AF,
ectopic foci may occur at a rate of 35%<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>.</p><p>The pioneers of the curative ablation in AF were cardiac surgeons. Cox's Maze-III
procedure started to be used in 1992 and has evolved by the compiling surgical
experiences built by the collection of worldwide mapping studies conducted in
animals and humans<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>. The
lesions are created by the cut-and-sew technique, following a median sternotomy. Cox
reported a permanent SR with this technique at a rate of 97%, which was found to be
84.9% in 2004, by a 1553-patient review<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>. The large patient series reported 30-day mortality rates
between 0-7.2% and a stroke rate of 0.5%, as well as the requirement for permanent
pacemakers at a rate of 5.8% and bleeding due to multiple incisions at a rate of
4.9%, therefore, the application of the procedure has been limited due to these high
mortality and morbidity rates for this somewhat benign arrhythmia<sup>[<xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r15" ref-type="bibr">15</xref>]</sup>. The Cox-Maze III procedure was applied in this study with
cryoablation as a relatively new technique. In this present study, a total of 80
patients with mitral valve disease who underwent cryoablation with Cox-Maze-III
procedure were included, and predefined patient factors which might potentially
affect the conversion to SR were evaluated. When the preoperative LAD values of the
patients were tied to the &#x0201c;sinus rhythm on the day of discharge&#x0201d; variable in the ROC
analysis, a cutoff value of 44.5 mm was found. When the preoperative LAD values were
tied to the &#x0201c;sinus rhythm in the first month&#x0201d; variable, a cutoff value of 45.5 mm
was found. No ties were made with other parameters. Based on the results of the
Chi-square test, the patients with LAD &#x02265; 46 mm were found to achieve higher
rates of conversion to SR on the day of discharge and in the first month compared to
the patients with LAD &#x02264; 45 mm. Many clinical investigators have set
thresholds of the LAD in order to predict the efficacy of surgical treatment of AF.
Melo et al.<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup> reported the
boundary of 5.5 cm and Yin et al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup> set the threshold at 5.8 cm and Cao et al.<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup> at 6.8 cm. In 2008, Breda Jr. et
al.<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup> published a
similar study with small amount of patients using radiofrequency for ablation,
reporting that two patients with LAD 65 and 68 mm presented with relapses of AF
rhythm after discharge.</p><p>A relatively smaller LAD is a more effective factor in determining the conversion to
the SR after the surgical ablation in AF patients; however, our study results showed
that LAD values &#x02265; 46 mm were more favorable in the early postoperative period
and in the first month. Although previous studies in the literature found out that
smaller LAD were more favorable for surgical ablation, the cutoff value of 45.5 mm
found in our study, which was smaller than the reported values by the previous
studies in the literature, suggested that LAD was not the only factor determining
the conversion to the SR.</p><p>For the preoperative EF values, a cutoff value of 48.5% was found based on the ROC
analysis&#x02019; results. A higher value of EF (%) in the early postoperative period was
found to be a significant factor in determining the conversion to the SR. A similar
result was also obtained when an empirically attributed value of 45% was used in the
analysis. However, all of these significant differences favoring the respective
groups of patients could not be observed in the six-month follow-up visits. In the
ROC analysis, no significant differences were observed in other variables including
gender, total duration of CPB, or duration of cross-clamping.</p><p>In the six-month follow-up visits, 14 patients (17.5%) required transient and six
patients (7.5%) required permanent pacemakers. Of these six patients, four required
the permanent pacemaker in the early period and the remaining two patients required
it in the late period. Since this study is limited to 80 patients without early
postoperative mortality, larger randomized studies are warranted to evaluate the
benefits to be achieved by the application of this actually controversial procedure
in the long term, as 7.5% of the patients required permanent pacemakers in this
study. In this procedure, the increased requirement for the placement of temporary
and permanent pacemakers is the most criticizing event.</p><p>Performance of the Maze procedure adjunctive to the mechanical valve replacement is
still debated as it is still uncertain whether it decreases the risk of TE events
alone when compared to the anticoagulant treatment. It hinders the recovery of
cardiac function in the early postoperative period by increasing the duration of the
CPB procedure and the cardiac ischemia. In addition, it increases the frequency of
bradyarrhythmias<sup>[<xref rid="r20" ref-type="bibr">20</xref>,<xref rid="r21" ref-type="bibr">21</xref>]</sup>. A 5466-patient review conducted
in 2005 followed up the patients for an average duration of 6.6 years and reported
that conversion to SR after the valvular surgery did not increase the survival or
decrease the number of TE events<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>. No mortality occurred in our study as well; however, 14
patients required temporary and six patients required permanent pacemakers. In 2008,
Gomes Junior et al.<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup> published
a similar study on 33 patients undergoing ablation with electrocautery for AF during
MVS. The authors presented parallel results to ours and reported low mortality and
morbidity rates. In our study, TE events occurred only in three patients in the
early postoperative period and no further TE events occurred in the six-month
follow-up period. Vural et al.<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>, in their recently published article (2018), have presented a
comparison of cryoablation and radiofrequency ablation in MVS. They reported that
there was no difference between the energy sources used for conversion to SR from
AF. And they reported also that the rate of TE events was low (2.3%). These data
suggested us that SR might be effective as much as the anticoagulant therapy for
protection from TE events. Bagge et al.<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup> compared MVS alone to MVS in combination with
cryoablation. They reported that left atrial cryoablation during MVS did not improve
the health-related quality of life in patients with permanent AF.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>In this study, we discussed some factors affecting the conversion to SR during the
postoperative period in patients with AF who underwent MVS with adjunct Cox-Maze III
procedure by cryoablation. The favorably significant differences in conversion to SR
were obtained on the day of discharge and at the postoperative follow-up visit only
in the group of patients with LAD &#x02265; 45.5 mm. At the same time, the rates of
conversion to SR during the early postoperative period were statistically higher in
patients with high left ventricular EF values than in those with low EF values.
However, these differences disappeared at the sixth-month follow-up visits. Of the
patients, 17.5% required temporary and 7.5% required permanent pacemakers. This
finding is one of the important aspects of this procedure to be criticized.
Conversion to SR and its maintenance during the postoperative period will affect the
cardiac functions and prevention of the TE events in the early period favorably.
Performing cryoablation in adjunct with MVS in patients with AF leads to a longer
duration of the surgical procedure, however, we are of the opinion that it may not
affect mortality and morbidity during the short and moderate terms. In addition, we
believe that the experience of the staff at the clinic, where the procedure is
performed, and the devices used during the procedure are important factors too. It
is observed that, in these patients, the benefits provided by the Cox-Maze III
procedure may be as effective as those of anticoagulation treatment.</p><p>Considering the publications in the literature and the results of our study, it is
clearly evident that comprehensive studies and extensive meta-analyses are required,
comparing the cases that were applied Cox-Maze III procedure to the ones who were
not.</p><table-wrap id="t8" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">FST</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; agreement to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MBE</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; agreement to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AD</td><td align="left" valign="top" rowspan="1" colspan="1">The acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at the Department of Cardiovascular Surgery,
University of Health Sciences, Elaz&#x00131;&#x0011f; Training and Research
Hospital, Elaz&#x00131;&#x0011f;, Turkey.</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrilich</surname><given-names>JR</given-names></name><name><surname>Hohnloser</surname><given-names>SH</given-names></name></person-group><article-title>Milestones in the management of atrial
fibrillation</article-title><source>Heart Rhythm</source><year>2009</year><volume>6</volume><issue>11 Suppl</issue><fpage>S62</fpage><lpage>S67</lpage><pub-id pub-id-type="doi">10.1016/j.hrthm.2009.07.016</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feinberg</surname><given-names>WM</given-names></name><name><surname>Blackshear</surname><given-names>JL</given-names></name><name><surname>Laupacis</surname><given-names>A</given-names></name><name><surname>Kronmal</surname><given-names>R</given-names></name><name><surname>Hart</surname><given-names>RG</given-names></name></person-group><article-title>Prevalence, age, distribution and gender of patients with atrial
fibrillation. Analysis and implications</article-title><source>Arch Intern Med</source><year>1995</year><volume>155</volume><issue>5</issue><fpage>469</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.1001/archinte.1995.00430050045005</pub-id><pub-id pub-id-type="pmid">7864703</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phan</surname><given-names>K</given-names></name><name><surname>Xie</surname><given-names>A</given-names></name><name><surname>Tian</surname><given-names>DH</given-names></name><name><surname>Shaikhrezai</surname><given-names>K</given-names></name><name><surname>Yan</surname><given-names>TD</given-names></name></person-group><article-title>Systemic review and meta-analysis of surgical ablation for atrial
fibrillation during mitral valve surgery</article-title><source>Ann Cardiothorac Surg</source><year>2014</year><volume>3</volume><issue>1</issue><fpage>3</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.3978/j.issn.2225-319X.2014.01.04</pub-id><pub-id pub-id-type="pmid">24516793</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>A</given-names></name><name><surname>Dinh</surname><given-names>D</given-names></name><name><surname>Dimitriou</surname><given-names>J</given-names></name><name><surname>Reid</surname><given-names>C</given-names></name><name><surname>Smith</surname><given-names>J</given-names></name><name><surname>Shardey</surname><given-names>G</given-names></name><etal/></person-group><article-title>Preoperative atrial fibrillation is an independent risk factor
for mid term mortality after concomitant aortic valve replacement and
coronary artery bypass graft surgery</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2013</year><volume>16</volume><issue>4</issue><fpage>488</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1093/icvts/ivs538</pub-id><pub-id pub-id-type="pmid">23287590</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barta</surname><given-names>J</given-names></name><name><surname>Brat</surname><given-names>R</given-names></name></person-group><article-title>Assessment of the effect of left atrial cryoablation enhanced by
ganglionated plexi ablation in the treatment of atrial fibrillation in
patients undergoing open heart surgery</article-title><source>J Cardiothorac Surg</source><year>2017</year><volume>12</volume><issue>1</issue><fpage>69</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1186/s13019-017-0625-1</pub-id><pub-id pub-id-type="pmid">28818088</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>JL</given-names></name><name><surname>Ad</surname><given-names>N</given-names></name><name><surname>Palazzo</surname><given-names>T</given-names></name><name><surname>Fitzpatrick</surname><given-names>S</given-names></name><name><surname>Suyderhoud</surname><given-names>JP</given-names></name><name><surname>DeGroot</surname><given-names>KW</given-names></name><etal/></person-group><article-title>Current status of the Maze procedure for the treatment of atrial
fibrillation</article-title><source>Semin Thorac Cardiovasc Surg</source><year>2000</year><volume>12</volume><issue>1</issue><fpage>15</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/S1043-0679(00)70011-6</pub-id><pub-id pub-id-type="pmid">10746917</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geidel</surname><given-names>S</given-names></name><name><surname>Ostermeyer</surname><given-names>J</given-names></name><name><surname>Lass</surname><given-names>M</given-names></name><name><surname>Boczor</surname><given-names>S</given-names></name><name><surname>Kuck</surname><given-names>KH</given-names></name></person-group><article-title>Surgical treatment of permanent atrial fibrillation during
cardiac surgery using monopolar and bipolar radiofrequency
ablation</article-title><source>Indian Pacing Electrophysiol J</source><year>2003</year><volume>3</volume><issue>3</issue><fpage>93</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">16943907</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaynor</surname><given-names>SL</given-names></name><name><surname>Schuessler</surname><given-names>RB</given-names></name><name><surname>Bailey</surname><given-names>MS</given-names></name><name><surname>Boineau</surname><given-names>JP</given-names></name><name><surname>Gleva</surname><given-names>MJ</given-names></name><name><surname>Cox</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Surgical treatment of atrial fibrillation: predictors of late
recurrence</article-title><source>J Thorac Cardiovasc Surg</source><year>2005</year><volume>129</volume><issue>1</issue><fpage>104</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2004.08.042</pub-id><pub-id pub-id-type="pmid">15632831</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>JL</given-names></name></person-group><article-title>Atrial fibrillation I: a new classification
system</article-title><source>J Thorac Cardiovasc Surg</source><year>2003</year><volume>126</volume><issue>6</issue><fpage>1686</fpage><lpage>1692</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2003.06.002</pub-id><pub-id pub-id-type="pmid">14688672</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgerton</surname><given-names>ZJ</given-names></name><name><surname>Edgerton</surname><given-names>JR</given-names></name></person-group><article-title>A review of current surgical treatment of patients with atrial
fibrillation</article-title><source>Proc (Bayl Univ Med Cent)</source><year>2012</year><volume>25</volume><issue>3</issue><fpage>218</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1080/08998280.2012.11928831</pub-id><pub-id pub-id-type="pmid">22754118</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Hao</surname><given-names>J</given-names></name><name><surname>Qin</surname><given-names>C</given-names></name><etal/></person-group><article-title>Bipolar radiofrequency ablation is useful for treating atrial
fibrillation combined with heart valve diseases</article-title><source>BMC Surg</source><year>2014</year><volume>14</volume><fpage>32</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1186/1471-2482-14-32</pub-id><pub-id pub-id-type="pmid">24884667</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>SA</given-names></name><name><surname>Tai</surname><given-names>CT</given-names></name></person-group><article-title>Catheter ablation of atrial fibrillation originating from the
non-pulmonary vein foci</article-title><source>J Cardiovasc Electrophysiol</source><year>2005</year><volume>16</volume><issue>2</issue><fpage>229</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1046/j.1540-8167.2005.40665.x</pub-id><pub-id pub-id-type="pmid">15720466</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>JL</given-names></name></person-group><article-title>Cardiac surgery for arrhythmias</article-title><source>Pacing Clin Electrophysiol</source><year>2004</year><volume>27</volume><issue>2</issue><fpage>266</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1111/j.1540-8159.2004.00426.x</pub-id><pub-id pub-id-type="pmid">14764186</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khargi</surname><given-names>K</given-names></name><name><surname>Hutten</surname><given-names>BA</given-names></name><name><surname>Lemke</surname><given-names>B</given-names></name><name><surname>Deneke</surname><given-names>T</given-names></name></person-group><article-title>Surgical treatment of atrial fibrillation; a systemic
review</article-title><source>Eur J Cardiothorac Surg</source><year>2005</year><volume>27</volume><issue>2</issue><fpage>258</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1016/j.ejcts.2004.11.003</pub-id><pub-id pub-id-type="pmid">15691679</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khargi</surname><given-names>K</given-names></name><name><surname>Keyhan-Falsafi</surname><given-names>A</given-names></name><name><surname>Hutten</surname><given-names>BA</given-names></name><name><surname>Ramanna</surname><given-names>H</given-names></name><name><surname>Lemke</surname><given-names>B</given-names></name><name><surname>Deneke</surname><given-names>T</given-names></name></person-group><article-title>Surgical treatment of atrial fibrillation: a systemic
review</article-title><source>Herzschrittmacherther Elektrophysiol</source><year>2007</year><volume>18</volume><issue>2</issue><fpage>68</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1007/s00399-007-0562-0</pub-id><pub-id pub-id-type="pmid">17646938</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melo</surname><given-names>J</given-names></name><name><surname>Santiago</surname><given-names>T</given-names></name><name><surname>Aguiar</surname><given-names>C</given-names></name><name><surname>Berglin</surname><given-names>E</given-names></name><name><surname>Knaut</surname><given-names>M</given-names></name><name><surname>Alfieri</surname><given-names>O</given-names></name><etal/></person-group><article-title>Surgery for atrial fibrillation in patients with mitral valve
disease: results at five years from the international registry of atrial
fibrillation surgery</article-title><source>J Thorac Cardiovasc Surg</source><year>2008</year><volume>135</volume><issue>4</issue><fpage>863</fpage><lpage>869</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2007.08.069</pub-id><pub-id pub-id-type="pmid">18374769</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>H</given-names></name></person-group><article-title>The midterm results of radiofrequency ablation and vagal
denervation in the surgical treatment of long-standing atrial fibrillation
associated with rheumatic heart disease</article-title><source>Thorac Cardiovasc Surg</source><year>2015</year><volume>63</volume><issue>3</issue><fpage>250</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1055/s-0034-1396932</pub-id><pub-id pub-id-type="pmid">25742550</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Tang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name></person-group><article-title>Late outcome of surgical radiofrequency ablation for persistent
valvular atrial fibrillation in China: a single-center study</article-title><source>J Cardiothorac Surg</source><year>2017</year><volume>12</volume><issue>1</issue><fpage>63</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1186/s13019-017-0627-z</pub-id><pub-id pub-id-type="pmid">28774344</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breda</surname><given-names>JR</given-names></name><name><surname>Breda</surname><given-names>ASCR</given-names></name><name><surname>Meneguini</surname><given-names>A</given-names></name><name><surname>Freitas</surname><given-names>ACO</given-names></name><name><surname>Pires</surname><given-names>AC</given-names></name></person-group><article-title>Surgical ablation of atrial fibrillation using
radiofrequency</article-title><source>Rev Bras Cir Cardiovasc</source><year>2008</year><volume>23</volume><issue>1</issue><fpage>118</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1590/s0102-76382008000100019</pub-id><pub-id pub-id-type="pmid">18719838</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaput</surname><given-names>M</given-names></name><name><surname>Bouchard</surname><given-names>D</given-names></name><name><surname>Demers</surname><given-names>P</given-names></name><name><surname>Perrault</surname><given-names>LP</given-names></name><name><surname>Cartier</surname><given-names>R</given-names></name><name><surname>Carrier</surname><given-names>M</given-names></name><etal/></person-group><article-title>Conversion to sinus rhythm does not improve long-term survival
after valve surgery: insights from a 20-year follow-up study</article-title><source>Eur J Cardiothorac Surg</source><year>2005</year><volume>28</volume><issue>2</issue><fpage>206</fpage><lpage>210</lpage><comment>discussion 210</comment><pub-id pub-id-type="doi">10.1016/j.ejcts.2005.03.014</pub-id><pub-id pub-id-type="pmid">15923118</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calkins</surname><given-names>H</given-names></name><name><surname>Brugada</surname><given-names>J</given-names></name><name><surname>Packer</surname><given-names>DL</given-names></name><name><surname>Cappato</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>SA</given-names></name><name><surname>Crijns</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>HRS/EHRA/ECAS expert consensus statement on catheter and surgical
ablation of atrial fibrillation: recommendations for personnel, policy,
procedures and follow-up. A report of the heart rhythm society (HRS) task
force on catheter and surgical ablation of atrial fibrillation developed in
partnership with the European heart rhythm association (EHRA) and the
European cardiac arrhythmia society (ECAS); in collaboration with the
American college of cardiology (ACC), American heart association (AHA), and
the society of thoracic surgeons (STS). Endorsed and approved by the
governing bodies of the American college of cardiology, the American heart
association, the European cardiac arrhythmia society, the European heart
rhythm association, the Society of thoracic surgeons, and the Heart rhythm
society</article-title><source>Europace</source><year>2007</year><volume>9</volume><issue>6</issue><fpage>335</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1093/europace/eum120</pub-id><comment>Erratum in: Europace. 2009;11(1):132</comment><pub-id pub-id-type="pmid">17599941</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watkins</surname><given-names>AC</given-names></name><name><surname>Young</surname><given-names>CA</given-names></name><name><surname>Ghoreishi</surname><given-names>M</given-names></name><name><surname>Shorofsky</surname><given-names>SR</given-names></name><name><surname>Gabre</surname><given-names>J</given-names></name><name><surname>Dawood</surname><given-names>MY</given-names></name><etal/></person-group><article-title>Prospective assessment of the CryoMaze procedure with continuous
outpatient telemetry in 136 patients</article-title><source>Ann Thorac Surg</source><year>2014</year><volume>97</volume><issue>4</issue><fpage>1191</fpage><lpage>1198</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2013.10.041</pub-id><pub-id pub-id-type="pmid">24582049</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes Junior</surname><given-names>JF</given-names></name><name><surname>Pontes</surname><given-names>JC</given-names></name><name><surname>Gomes</surname><given-names>OM</given-names></name><name><surname>Duarte</surname><given-names>JJ</given-names></name><name><surname>Gardenal</surname><given-names>N</given-names></name><name><surname>Dias</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Surgical treatment of chronic atrial fibrillation with
conventional electrocautery in mitral valve surgery</article-title><source>Rev Bras Cir Cardiovasc</source><year>2008</year><volume>23</volume><issue>3</issue><fpage>365</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1590/s0102-76382008000300013</pub-id><pub-id pub-id-type="pmid">19082325</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vural</surname><given-names>U</given-names></name><name><surname>Balci</surname><given-names>AY</given-names></name><name><surname>Aglar</surname><given-names>AA</given-names></name><name><surname>Kizilay</surname><given-names>M</given-names></name></person-group><article-title>Which method to use for surgical ablation of atrial fibrillation
performed concomitantly with mitral valve surgery: radiofrequency ablation
versus cryoablation</article-title><source>Braz J Cardiovasc Surg</source><year>2018</year><volume>33</volume><issue>6</issue><fpage>542</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.21470/1678-9741-2018-0130</pub-id><pub-id pub-id-type="pmid">30652742</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagge</surname><given-names>L</given-names></name><name><surname>Probst</surname><given-names>J</given-names></name><name><surname>Jensen</surname><given-names>SM</given-names></name><name><surname>Blomstrom</surname><given-names>P</given-names></name><name><surname>Thelin</surname><given-names>S</given-names></name><name><surname>Holmgren</surname><given-names>A</given-names></name><etal/></person-group><article-title>Quality of life is not improved after mitral valve surgery
combined with epicardial left atrial cryoablation as compared with mitral
valve surgery alone: a substudy of the double-blind randomized SWEDish
multicentre atrial fibrillation study (SWEDMAF)</article-title><source>Europace</source><year>2018</year><volume>20</volume><issue>FI_3</issue><fpage>f343</fpage><lpage>f350</lpage><pub-id pub-id-type="doi">10.1093/europace/eux253</pub-id><pub-id pub-id-type="pmid">29016835</pub-id></element-citation></ref></ref-list></back></article>